Brown, Lisle/Cummings’s Labcorp LH Stock Holding History

Brown, Lisle/Cummings’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$83K	Buy	311 +11	+4%	+$2.98K	0.02%	302
2025 Q4	$75.3K	Hold	300	–	–	0.02%	306
2025 Q3	$86.1K	Hold	300	–	–	0.02%	293
2025 Q2	$78.8K	Hold	300	–	–	0.02%	294
2025 Q1	$69.8K	Hold	300	–	–	0.02%	301
2024 Q4	$68.8K	Hold	300	–	–	0.02%	300
2024 Q3	$67K	Hold	300	–	–	0.02%	294
2024 Q2	$61.1K	Hold	300	–	–	0.02%	298
2024 Q1	$65.5K	Hold	300	–	–	0.02%	271
2023 Q4	$68.2K	Hold	300	–	–	0.03%	262
2023 Q3	$60.3K	Sell	300 -49	-14%	-$10.3K	0.03%	255
2023 Q2	$72.4K	Hold	349	–	–	0.03%	251
2023 Q1	$68.8K	Hold	349	–	–	0.03%	249
2022 Q4	$70.6K	Buy	349 +145	+71%	+$28.3K	0.04%	240
2022 Q3	$35.8K	Buy	204 +58	+40%	+$11.9K	0.02%	279
2022 Q2	$29.3K	Hold	146	–	–	0.02%	293
2022 Q1	$33K	Buy	146 +88	+152%	+$20.7K	0.02%	301
2021 Q4	$15.7K	Buy	+58	New	+$14.4K	0.01%	351

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brown, Lisle/Cummings's LH Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Labcorp (LH) stake by 3.7% in Q1 2026, buying an estimated $2.98K and bringing the position to 311 shares worth $83K. The position accounts for 0.02% of the portfolio, ranked #302.

Brown, Lisle/Cummings first reported a position in LH in Q4 2021 and has held it in 18 quarters since. The position peaked at $86.1K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Brown, Lisle/Cummings held 311 shares of Labcorp worth $83K as of Q1 2026.
Brown, Lisle/Cummings bought 11 Labcorp shares in Q1 2026, an estimated $2.98K.
Labcorp made up 0.02% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #302 holding.
Brown, Lisle/Cummings first reported a position in Labcorp in Q4 2021 and has held it in 18 quarters since.
Brown, Lisle/Cummings's Labcorp position peaked at $86.1K in Q3 2025.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.